Clinical Trial Update: The Effect of Diflunisal on Familial Transthyretin Amyloidosis

View source ↗

Summary

Completed clinical trial evaluating the NSAID diflunisal for hereditary transthyretin-mediated amyloidosis (familial transthyretin amyloidosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin-mediated Amyloidosis
• Transthyretin Amyloidosis

Drugs mentioned

• DIFLUNISAL (Diflunisal)

Snippet

Sponsor: Umeå University | Conditions: Amyloidosis | Status: COMPLETED